KBP Biosciences

Kbp Biosciences

Pharmaceuticals, 116 Village BLVD Ste 210, Princeton, New Jersey, 08540, United States, 51-200 Employees

kbpbiosciences.com

  • LinkedIn

Who is KBP BIOSCIENCES

At KBP we are consistently reminded that patient care is the end goal of what we do daily. Our discovery team is highly experienced in identifying new compounds with potential. The close ...

Read More

map
  • 116 Village BLVD Ste 210, Princeton, New Jersey, 08540, United States Headquarters: 116 Village BLVD Ste 210, Princeton, New Jersey, 08540, United States
  • 2007 Date Founded: 2007
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 8731 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from KBP BIOSCIENCES

KBP Biosciences Org Chart and Mapping

Employees

Fred Yang

Chief Development Officer/Senior Vice President

James McCabe

Deputy Chief Medical Officer

Mike Wang

Associate Medical Director

Bs Diego Gomes

Associate Medical Director

Julia Yang

Chief Operating Officer, Global Clinical Development, Global R&D

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding KBP Biosciences

Answer: KBP Biosciences's headquarters are located at 116 Village BLVD Ste 210, Princeton, New Jersey, 08540, United States

Answer: KBP Biosciences's official website is https://kbpbiosciences.com

Answer: KBP Biosciences's revenue is $10 Million to $25 Million

Answer: KBP Biosciences's SIC: 8731

Answer: KBP Biosciences's NAICS: 541714

Answer: KBP Biosciences has 51-200 employees

Answer: KBP Biosciences is in Pharmaceuticals

Answer: KBP Biosciences contact info: Phone number: Website: https://kbpbiosciences.com

Answer: At KBP we are consistently reminded that patient care is the end goal of what we do daily. Our discovery team is highly experienced in identifying new compounds with potential. The close interactions of the discovery and development teams result in a deep pipeline with multiple clinical and pre-clinical compounds. The major organ research group is focused on the maintenance and postponement of disease progression of three primary organ systems lung, heart, and kidney and is capable of assessing a drugs activity and active mechanism in both in vitro and in vivo models. The antimicrobial group, leverages a proprietary microbial bank comprised of 20,000+ clinically-isolated strains, including anaerobic bacteria and fungi, to evaluate internally generated drug candidates effectively. The immunology group conducts research on the roles of T- and B-cells in rheumatoid arthritis, hyperuricemia, idiopathic pulmonary fibrosis, among others. Our laser-focus on these three therapeutic areas provides powerful and unique insights on the underlying physiological and pathological processes that drive disease, opening up new avenues to tackle specific targets. Our researchers use their expertise to locate these new directions and exploit them, resulting in innovative therapies for a wide variety of illnesses.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access